Latest Breaking News On - Austin speier - Page 1 : comparemela.com

Click Therapeutics and Boehringer Ingelheim Announce FDA Breakthrough Device Designation for Prescription Digital Therapeutic to Treat Negative Symptoms of Schizophrenia

Click Therapeutics and Boehringer Ingelheim Announce FDA Breakthrough Device Designation for Prescription Digital Therapeutic to Treat Negative Symptoms of Schizophrenia
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

United statesAustin speierShaheen lakhanChristine sakdalanDrug administrationAnimal healthWorld health organizationClick therapeutics incBreakthrough devices programBoehringer ingelheimSchizophrenia world health organizationProduct serviceNational institute of mental healthMental healthBoehringer ingelheim announceDevice designation

Q&A: How pharma partnerships could benefit digital therapeutics companies

Austin Speier, chief strategy officer at Click Therapeutics, discusses the company's expanded partnership with Boehringer Ingelheim.

Austin speierBoehringer ingelheimClick therapeutics

Boehringer Ingelheim and Click Therapeutics expand their existing Collaboration to develop Prescription Digital Therapeutics for Schizophrenia

Boehringer Ingelheim and Click Therapeutics expand their existing Collaboration to develop Prescription Digital Therapeutics for Schizophrenia
q8dailynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from q8dailynews.com Daily Mail and Mail on Sunday newspapers.

Nedim pipicAustin speierDavid benshoof kleinCornelia dorner ciossekDigital health lead at boehringer ingelheimBoehringer ingelheimClick therapeuticsCorporate vice presidentTherapeutic area headEmerging areasDigital health leadChief strategy officerPress release view

Boehringer Ingelheim, Click Therapeutics expand partnership to develop prescription digital therapeutics

The companies first partnered in 2020 to develop a prescription digital therapeutic for schizophrenia. They said a treatment strategy for the condition "would benefit from a multi-product approach."

Austin speierDavid kleinSilicon valley bankBoehringer ingelheimClick therapeuticsDevice designation

Click Therapeutics wins breakthrough nod for PDT for migraines

Click Therapeutics announced that it received FDA breakthrough device designation for its CT-132 prescription digital therapeutic (PDT).

Austin speierShaheen lakhanStewart tepperGeisel school of medicine at dartmouthDartmouth headache centerClick therapeuticsYork based clickClick neurobehavioral interventionGeisel schoolDartmouth headache